KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Medtronic (MDT) Shares Issued (2016 - 2026)

Medtronic's Shares Issued history spans 13 years, with the latest figure at $164.0 million for Q1 2026.

  • On a quarterly basis, Shares Issued fell 2.38% to $164.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $527.0 million, a 10.25% increase, with the full-year FY2025 number at $508.0 million, up 78.87% from a year prior.
  • Shares Issued hit $164.0 million in Q1 2026 for Medtronic, up from $160.0 million in the prior quarter.
  • Over the last five years, Shares Issued for MDT hit a ceiling of $168.0 million in Q1 2025 and a floor of $43.0 million in Q3 2022.
  • Historically, Shares Issued has averaged $98.5 million across 5 years, with a median of $89.0 million in 2024.
  • Biggest five-year swings in Shares Issued: plummeted 64.1% in 2022 and later soared 194.74% in 2025.
  • Tracing MDT's Shares Issued over 5 years: stood at $110.0 million in 2022, then crashed by 34.55% to $72.0 million in 2023, then skyrocketed by 98.61% to $143.0 million in 2024, then grew by 11.89% to $160.0 million in 2025, then grew by 2.5% to $164.0 million in 2026.
  • Business Quant data shows Shares Issued for MDT at $164.0 million in Q1 2026, $160.0 million in Q4 2025, and $95.0 million in Q3 2025.